Drugs.com FDA MedWatch AlertsOriginal article
Unique Pharmaceutical Laboratories Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine
RegulatoryCetirizine Hydrochloride Tablets USP 5 mgNegative
AI Analysis
Summary
Unique Pharmaceutical Laboratories, a division of J. B. Chemicals & Pharmaceuticals Ltd., voluntarily recalled four lots of Cetirizine Hydrochloride Tablets USP 5 mg due to potential cross contamination with ranitidine.
Outcome Details
Voluntary recall of four lots due to potential cross contamination with ranitidine
Importance:3/10
Sentiment:
-0.70
product recallquality controlcontaminationconsumer safety
Related Companies
Read the original article
Published by Drugs.com FDA MedWatch Alerts on July 18, 2026 1:18 PM